NIDA Research Monograph, Number 134 [Printed in 1993]
If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able
to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.
This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.
Download Monograph134.pdf - Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Design (2.9 MB)
Table of Contents
Strategies for Drug Discovery-----1
Michael Williams
Mass Ligand-Binding Screening Strategies for Identification of Leads for New Drug Discovery-----37
Ronald M. Burch
Antibody- and Peptide Structure-Based Drug Design-----46
Manfred E. Wolff
The Use of Cloned Human Receptors for Drug Design-----56
Paul R. Hartig
Synthetic Peptide Combinatorial Libraries May Be Used To Determine Peptide Ligands for Opioid Receptors-----66
Richard A. Houghten and Colette T. Dooley
Preparation of Large Peptide Libraries With One Peptide per Bead and Their Use for the Discovery of Peptides That Bind to Acceptors-----75
Victor J. Hruby, Kit S. Lam, Michal Lebl, Wieslaw Kazmierski, Evan M. Hersh, and Sydney E. Salmon
Computer Design of Bioactive Compounds Based on 3-D Properties of Ligands-----64
Y.C. Martin
Toward the Design of New Inhibitors: A Computer Modeling Approach-----103
Carlos H. Faerman
Efforts To Improve the Utilization of Protein Sequence and Structure Databases-----114
Nagarajan Pattabiraman and Krishnan Namboodiri
Use of Computer Graphics in Drug Design-----129
G. W.A. Milne and M.C. Nicklaus
Purification and Cloning of Opioid Receptors-----146
Ling-Yuan Li, Ying-Fu Su, Zeng-Ming Zhang, Chih-Shung Wong, and Kwen-Jen Chang
Computer-Assisted Design of Dopamine Transporter Ligands-----165
Gilda H. Loew, Hugo 0. Villar, Patricia A. Maguire, and M. Frances Davies
The Pharmacophore for Opioid Activity-----178
Mark Froimo witz
The Molecular Basis of Opioid Potency and Selectivity: Morphiceptins, Dermorphins, Deltorphins, and Enkephalins-----195
Murray Goodman, Seonggu Ro, George …sapay, Toshimasa Yamazaki, and Alexander Polinsky
Molecular Determinants of Cannabinoid Activity: Toward the Design of Cannabinoid Analgesics With Reduced Psychoactive Liability-----210
Patricia H. Reggio
Cocaine Receptor: A Structure-Activity Relationship Study-----229
F. Ivy Carroll, Anita H. Lewin, Michael J. Kuhar, and John W. Baja
The Use of Conformational Restriction and Molecular Modeling Techniques in the Development of Receptor-Specific Opioid Peptide Agonists and Antagonists-----236
Peter W. Schiller, Thi M.-D. Nguyen, Grazyna Weltrowska, Nga N. Chung, Carole Lemieux, Brian J. Marsden, and Brian C. Wilkes
Probes for the Cannabinoid Sites of Action-----253
Alexandros Makriyannis
A Model for the Structural Basis of -Opiloid Receptor Selectivity-----266
Henry I. Mosberg and Frank Porreca
List of NIDA Research Monographs-----281
|